Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Incannex HealthcareIXHL -5.45%32 Current Ratio is 41.56 as of Mar. 2026, which is 949% above its 10-year median of 3.96. GuruFocus rates IXHL with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 999 Drug Manufacturers companies, Incannex Healthcare ranks better than 99.4% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Incannex Healthcare's current ratio for the quarter that ended in Mar. 2026 was 41.56.
Incannex Healthcare has a current ratio of 41.56. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Incannex Healthcare's Current Ratio or its related term are showing as below:
IXHL'
s Current Ratio Range Over the Past 10 Years
Min: 0.41 Med: 3.96 Max: 48.27
Current: 41.56
During the past 13 years, Incannex Healthcare's highest Current Ratio was 48.27. The lowest was 0.41. And the median was 3.96.
IXHL's Current Ratio is ranked better than 99.4% of 999
companies
in the Drug Manufacturers industry
Industry Median: 2
vs IXHL: 41.56
Incannex Healthcare (NAS:IXHL) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Incannex Healthcare Current Ratio Related Terms
Incannex Healthcare Current Ratio Historical Data
* Premium members only.
The historical data trend for Incannex Healthcare's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IXHL vs ETST, SCYX, INIS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Incannex Healthcare Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's Current Ratio distribution charts can be found below:
* The bar in red indicates where Incannex Healthcare's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Incannex Healthcare (IXHL) has a Current Ratio of 41.56 as of Mar. 2026. This is 949% above median its historical median of 3.96. Over the past decade, Incannex Healthcare's Current Ratio has ranged from 0.41 to 48.27. According to the industry distribution chart, Incannex Healthcare ranks #6 out of 999 companies in the Drug Manufacturers industry, placing it in the top 0.59999999999999%.
Is Incannex Healthcare's Current Ratio too high?
Incannex Healthcare's current Current Ratio of 41.56 is 949% above median its 10-year median of 3.96. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 48.27. The Drug Manufacturers industry median Current Ratio is 2.00. Incannex Healthcare's value of 41.56 is 1978% above this industry median. Based on the distribution chart, Incannex Healthcare ranks #6 out of 999 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Incannex Healthcare has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Incannex Healthcare's Current Ratio compare to ETST and SCYX?
According to the Drug Manufacturers industry distribution chart, Incannex Healthcare ranks #6 out of 999 companies for Current Ratio. This places Incannex Healthcare in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.00. Incannex Healthcare's value of 41.56 is 1978% above this benchmark. Historically, Incannex Healthcare's own Current Ratio has ranged from 0.41 to 48.27 over the past decade. While the company's 10-year median is 3.96 vs. the industry median of 2.00, Incannex Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Incannex Healthcare's current Current Ratio of 41.56 is 1978% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Incannex Healthcare's current Current Ratio is 41.56, which is 949% above median its own 10-year median of 3.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incannex Healthcare stock overvalued right now?
Incannex Healthcare (IXHL) has a current Current Ratio of 41.56. The current Current Ratio is 41.56, which is 949% above median its 10-year median of 3.96 and 1978% above the Drug Manufacturers industry median of 2.00. Incannex Healthcare's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Incannex Healthcare (IXHL), the current Current Ratio is 41.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
32GF Score
Get the complete analysis for IXHL
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IXHL has been successfully added to your 
